Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs DOACs)

NCT03568916 · clinicaltrials.gov ↗

COMPLETED

Status

227579

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Ischemic Stroke
Systemic Embolization
Major Bleed
Myocardial Infarction
All-cause Mortality

Interventions

DRUG: Apixaban (ATC B01AF02)
DRUG: Dabigatran (ATC B01AE07)
DRUG: Rivaroxaban (ATC B01AF01)

Sponsor

Canadian Network for Observational Drug Effect Studies, CNODES

Collaborators

[object Object]
[object Object]